AI-generated summary
The authors studied 830 nm low reactive level laser therapy in mice with implanted gliomas, using two experimental models and several treatment combinations. They report that laser therapy applied from the first day after implantation, both directly and indirectly, inhibited tumor growth, with the combination of direct laser and mouse beta-interferon appearing most effective. The authors also note the effect might be dose-dependent.
- Who or what was studied
- Mice with implanted glioma
- Wavelengths
- 830 nm
- Limits stated in the abstract
- The study was conducted in mice, and the abstract is truncated, so full methods and sample sizes are not available.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on jstage.jst.go.jp.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 830 nm
- Power
- 60 mW
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Laser, Control group, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.